Clinical Trial Update: Adaptive Trial Scheduling in Naming Treatment for Aphasia [Phase 2]

View source ↗

Summary

A Phase 2 adaptive clinical trial from the University of Pittsburgh is testing a naming treatment for aphasia related to stroke and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphasia
• Stroke

Snippet

Sponsor: University of Pittsburgh | Conditions: Aphasia, Stroke | Phase 2 | Status: RECRUITING